
Afanat 40mg contains Afatinib, a targeted cancer therapy used to treat non-small cell lung cancer (NSCLC) that is EGFR mutation-positive.
| Generic Name | Afatinib |
| Manufacturer | Natco Pharma Ltd |
| Packing | 28 Tablets |
| Prescribed For | Lung Cancer |
| Availability | In Stock |




We are a trusted supplier of generic anticancer medicines, providing authentic Afanat (Afatinib 40mg) tablets widely used for the treatment of non-small cell lung cancer (NSCLC).
Our secure, reliable, and timely bulk supply of generic oncology drugs, including Afatinib (Gilotrif), serves hospitals, clinics, pharmacies, healthcare institutions, physicians, NGOs, and authorized buyers in over 80 countries worldwide. Our global reach spans Latin America, Africa, Asia, Europe, the Middle East, and North America, covering key markets such as Mexico, Brazil, Colombia, Peru, Chile, UAE, Saudi Arabia, Egypt, South Africa, Namibia, Kenya, Nigeria, Singapore, Vietnam, Thailand, the Philippines, Canada, and more.
Disclaimer
This website operates in compliance with applicable pharmaceutical laws. All content and data available on this website are intended solely for informational purposes. The information provided is not a substitute for professional medical advice, diagnosis, or treatment. Information provided here is for general awareness and does not replace medical advice. We strongly encourage you to consult a qualified healthcare professional for guidance.